IND‐enabling studies to support the clinical development of ATSN‐201, a subretinally delivered, laterally spreading gene replacement therapy for X‐Linked Retinoschisis (XLRS)

rAAV2tYF-CB-hRS1 - AGTC

ATSN-201 - Atsena Therap

https://www.liebertpub.com/doi/epub/10.1089/hum.2023.29258.abstracts

E Andres‐Mateos1; H Zhang2; D Fajardo2; J J Peterson2; E Xu2; C Kozlowski1; I Navas‐Enamorado1; K R Calabro1; S Rayaprolu1; C Plummer2; K Coleman2; S L Boye2; S E Boye2

Aug 29, 2023